Biotechnology and Health Care
Currently Funded Centers
ASSIST intends to harness nanotechnology to improve global health by enabling correlation between personal health and personal environment and by empowering patients and doctors to manage wellness and improve quality of life.
CSNE will seek to identify the engineering principles of neural movement control and sensory processing to enable a new generation of robust, adaptive, closed loop, sensorimotor devices that interact with human nervous systems.
RMB is developing the fundamental knowledge and technology needed to advance biocompatible and biodegradable metal-based, implantable systems with feedback control for reconstruction and regeneration.
Graduated Centers (Self-sustaining)
Focusing on medical devices, biomaterials, and tissue engineering with the goals of improving therapies, reducing healthcare costs, and educating a next generation of biomaterials scientists
VaNTH is engaged in efforts to transform bioengineering education by developing, implementing, and assessing educational processes, materials, and learning technologies.
Inspired by fundamental discoveries about microbial communities on surfaces, the CBE develops solutions to industrially relevant biofilm problems and engineers uses for beneficial microbial biofilms
Integrating life sciences and bioprocess engineering with the goal of producing advanced manufacturing technologies
Develop surgical systems that integrate novel computer and human/machine interface technologies that will revolutionize surgical procedures, extending the surgeon's abilities to achieve better outcomes at lower costs
Integrate engineering technologies, biological discoveries, and clinical expertise and infrastructure so as to fundamentally transform the treatment of human diseases and injuries through the development and translation of new technologies that enhance the body’s ability to heal itself
UWEB brings together a cross-disciplinary team of scientists, biologists, engineers, researchers and physicians, as well as industry leaders, to exploit specific biological mechanisms in the development of medical innovations.